Mizuho Securities Sticks to Its Buy Rating for Axsome Therapeutics (AXSM)
In a report released today, Graig Suvannavejh from Mizuho Securities reiterated a Buy rating on Axsome Therapeutics (AXSM – Research Report), ...
Mizuho Securities Sticks to Their Hold Rating for Apellis Pharmaceuticals (APLS)
In a report released today, Graig Suvannavejh from Mizuho Securities maintained a Hold rating on Apellis Pharmaceuticals (APLS – Research ...